Vaccinex

$2.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-3.90%) Today
+$0.09 (+3.32%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Vaccinex and other stocks, options, and ETFs commission-free!

About VCNX

Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases and autoimmune disorders.

CEO
Maurice Zauderer
Employees
39
Headquarters
Rochester, New York
Founded
1997
Market Cap
79.26M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
355.92K
High Today
$2.86
Low Today
$2.71
Open Price
$2.78
Volume
256.82K
52 Week High
$9.56
52 Week Low
$1.63

VCNX Earnings

-$0.58
-$0.39
-$0.19
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, Pre-Market

You May Also Like

SEKEY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure